Dr. Eric Kang Ting graduated from Harvard school of Dental Medicine with high honor and the gold award with DMD in 1991 and PhD, and an orthodontic certificate from Harvard in 1994. He currently is an adjunct faculty at the ADA Forsyth Institute, Cambridge, MA, USA. He was formerly the Academic Senate Tenured Professor since 2002 and founding chair in the Division of Growth and Development at UCLA. The Division comprises the Sections of Orthodontics and Pediatric Dentistry. Besides his teaching and clinical responsibilities in Orthodontics. Dr. Ting has google scholar h-index of 62 – as one of the top three highest orthodontists globally. Ting’s original research has received well over 12,000 citations. It has been published in many leading journals, including Nature Communications, Journal of Clinical Investigation, PLOS One, and Biomaterials, etc as the principal author. Dr. Ting has been served as a PARC AAOF committee member since 2015. In 2018, Professor Ting and his team received the International Space Station (ISS) Innovation Award for Biology and Medicine for Development of NELL-1 Bone-Growth Systemic Therapy by the American Astronautical Society. Dr. Ting has received over US 30M in funding from the US government as a key investigator in his career.  Stemmed from his research, two novel biologic drugs are currently in FDA clinical trials for scar reduction, and bone regeneration respectively.